Next Article in Journal
Dose Optimization of Targeted Therapies for Oncologic Indications
Previous Article in Journal
A Description and Safety Overview of Irreversible Electroporation for Prostate Tissue Ablation in Intermediate-Risk Prostate Cancer Patients: Preliminary Results from the PRESERVE Trial
Previous Article in Special Issue
The m7G Reader NCBP2 Promotes Pancreatic Cancer Progression by Upregulating MAPK/ERK Signaling
 
 
Review

Article Versions Notes

Cancers 2024, 16(12), 2179; https://doi.org/10.3390/cancers16122179
Action Date Notes Link
article xml file uploaded 8 June 2024 12:18 CEST Original file -
article xml uploaded. 8 June 2024 12:18 CEST Update https://www.mdpi.com/2072-6694/16/12/2179/xml
article pdf uploaded. 8 June 2024 12:18 CEST Version of Record https://www.mdpi.com/2072-6694/16/12/2179/pdf
article html file updated 8 June 2024 12:20 CEST Original file https://www.mdpi.com/2072-6694/16/12/2179/html
Back to TopTop